Lights, fluorescence, action—Influencing wound treatment plans including debridement of bacteria and biofilms
International Wound Journal · 2023-10 · 20 (8) · 3279-3288
DOI: 10.1111/iwj.14208 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Wound Journal, online erschienen am 03.05.2023. Verfasst von Ashley Jacob und 11 weiteren Autor:innen. Beteiligte Einrichtung: MolecuLight Inc., Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Wound Infection. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
High bacterial loads within chronic wounds increase the risk of infection and complication. Detection and localization of bacterial loads through point‐of‐care fluorescence (FL) imaging can objectively inform and support bacterial treatment decisions. This single time‐point, retrospective analysis describes the treatment decisions made on 1000 chronic wounds (DFUs, VLUs, PIs, surgical wounds, burns, and others) at 211 wound‐care facilities across 36 US states. Clinical assessment findings and treatment plans derived from them, as well as subsequent FL‐imaging (MolecuLight®) findings and any associated treatment plan changes, were recorded for analysis. FL signals indicating elevated bacterial loads were observed in 701 wounds (70.8%), while only 293 (29.6%) showed signs/symptoms of infection. After FL‐imaging, treatment plans changed in 528 wounds as follows: more extensive debridement (18.7%), more extensive hygiene (17.2%), FL‐targeted debridement (17.2%), new topical therapies (10.1%), new systemic antibiotic prescriptions (9.0%), FL‐guided sampling for microbiological analysis (6.2%), and changes in dressing selection (3.2%). These real‐world findings of asymptomatic bacterial load/biofilm incidence, and of the frequent treatment plan changes post‐imaging, are in accordance with clinical trial findings using this technology. These data, from a range of wound types, facilities, and clinician skill sets, suggest that point‐of‐care FL‐imaging information improves bacterial infection management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- MolecuLight Inc., Toronto, Ontario, Canada.
- St. Louis Foot & Ankle, St. Louis, Missouri, USA.
- Adamant Medical Group, Pittsburgh, Pennsylvania, USA.
- Atlantic Health, Morristown, New Jersey, USA.
- Clara Maass Medical Center, Belleville, New Jersey, USA.
- Agiliti Health, Inc., Minneapolis, Minnesota, USA.
Zitieren
APA
Jacob, A., Jones, L. M., Abdo, R. J., Cruz-Schiavone, S. F., Skerker, R., Caputo, W. J., Krehbiel, N., Moyer-Harris, A. K., McAtee, A., Baker, I., Gray, M. D., & Rennie, M. Y. (2023). Lights, fluorescence, action—Influencing wound treatment plans including debridement of bacteria and biofilms. International Wound Journal, 20(8), 3279-3288. https://doi.org/10.1111/iwj.14208
Vancouver
Jacob A, Jones LM, Abdo RJ, Cruz-Schiavone SF, Skerker R, Caputo WJ, et al. Lights, fluorescence, action—Influencing wound treatment plans including debridement of bacteria and biofilms. International Wound Journal. 2023;20(8):3279-3288. doi:10.1111/iwj.14208
BibTeX
@article{Jacob2023,
author = {Jacob, Ashley and Jones, Laura M and Abdo, Raymond J and Cruz-Schiavone, Sebastian F and Skerker, Robert and Caputo, Wayne J and Krehbiel, Nathan and Moyer-Harris, Audrey K and McAtee, Alyssa and Baker, Isabel and Gray, Micaela D and Rennie, Monique Y},
title = {Lights, fluorescence, action—Influencing wound treatment plans including debridement of bacteria and biofilms},
journal = {International Wound Journal},
year = {2023},
volume = {20},
number = {8},
pages = {3279--3288},
doi = {10.1111/iwj.14208}
}
EUVIMED